Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGS - Nasdaq Real Time Price USD

Guardant Health, Inc. (GH)

Compare
44.97
-0.21
(-0.46%)
At close: April 17 at 4:00:01 PM EDT
45.50
+0.53
+(1.18%)
After hours: April 17 at 7:16:56 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
739,016
739,016
563,948
449,538
373,653
Cost of Revenue
289,799
289,799
227,052
156,325
122,912
Gross Profit
449,217
449,217
336,896
293,213
250,741
Operating Expense
892,811
892,811
901,621
837,591
661,742
Operating Income
-443,594
-443,594
-564,725
-544,378
-411,001
Net Non Operating Interest Income Expense
51,110
51,110
32,787
3,492
1,353
Other Income Expense
-42,605
-42,605
53,174
-112,563
25,178
Pretax Income
-435,089
-435,089
-478,764
-653,449
-384,470
Tax Provision
1,284
1,284
685
1,139
300
Net Income Common Stockholders
-436,373
-436,373
-479,449
-654,588
-405,670
Diluted NI Available to Com Stockholders
-436,373
-436,373
-479,449
-654,588
-405,670
Basic EPS
-3.56
-3.56
-4.28
-6.41
-4.00
Diluted EPS
-3.56
-3.56
-4.28
-6.41
-4.00
Basic Average Shares
122,745
122,745
111,988
102,178
101,314
Diluted Average Shares
122,745
122,745
111,988
102,178
101,314
Total Operating Income as Reported
-443,594
-443,594
-564,725
-544,378
-411,001
Total Expenses
1,182,610
1,182,610
1,128,673
993,916
784,654
Net Income from Continuing & Discontinued Operation
-436,373
-436,373
-479,449
-654,588
-405,670
Normalized Income
-436,373
-436,373
-479,449
-654,588
-405,670
Interest Income
53,691
53,691
35,365
6,069
3,930
Interest Expense
2,581
2,581
2,578
2,577
2,577
Net Interest Income
51,110
51,110
32,787
3,492
1,353
EBIT
-432,508
-432,508
-476,186
-650,872
-381,893
EBITDA
-390,121
-390,121
-433,305
-614,910
-359,622
Reconciled Cost of Revenue
289,799
289,799
227,052
156,325
122,912
Reconciled Depreciation
42,387
42,387
42,881
35,962
22,271
Net Income from Continuing Operation Net Minority Interest
-436,373
-436,373
-479,449
-654,588
-405,670
Normalized EBITDA
-390,121
-390,121
-433,305
-614,910
-359,622
Tax Rate for Calcs
0
0
0
0
0
12/31/2021 - 10/4/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EXAS Exact Sciences Corporation
41.58
-1.61%
 
NTRA Natera, Inc.
148.08
-1.39%
 
VCYT Veracyte, Inc.
31.14
-1.24%
 
WGS GeneDx Holdings Corp.
95.47
-2.86%
 
GRAL GRAIL, Inc.
27.00
+1.89%
 
TWST Twist Bioscience Corporation
36.80
-4.29%
 
ILMN Illumina, Inc.
71.20
-3.17%
 
DGX Quest Diagnostics Incorporated
163.80
-0.41%
 
MYGN Myriad Genetics, Inc.
7.64
-3.41%
 
PSNL Personalis, Inc.
3.1900
-3.04%